Condition
Staphylococcus Aureus Bloodstream Infection
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 4 (2)
Trial Status
Recruiting3
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07612813Phase 1RecruitingPrimary
A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults
NCT06650501Phase 4Recruiting
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
NCT06650488Phase 4Recruiting
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
NCT06014736Phase 1UnknownPrimary
A Phase I Study of XJ101 in Chinese Healthy Subjects
Showing all 4 trials